Insiders · CLBT

Thomas E. Hogan

Advisor at Cellebrite DI Ltd. (CLBT)

Thomas E. Hogan has filed 3 insider reports with the SEC since July 2026, as advisor at Cellebrite DI Ltd. (CLBT). In the last 12 months Thomas E. Hogan sold $4.06M of stock on the open market. In the latest filing, on August 27, 2026, Thomas E. Hogan sold 25,299 shares of Cellebrite DI Ltd. (CLBT) for $286K at an average of $11.29.

Filings
3
Companies
1
Bought on market
None
Sold on market
$4.06M

Companies where Thomas E. Hogan is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Cellebrite DI Ltd. logo
CLBT
Cellebrite DI Ltd.
Advisor765,249$4.06M$11.16Aug 27, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Thomas E. Hogan with

Other insiders at the same companies

Questions about Thomas E. Hogan

What is Thomas E. Hogan's role at Cellebrite DI Ltd.?
Thomas E. Hogan reports to the SEC as advisor at Cellebrite DI Ltd. (CLBT), according to the latest filing on August 27, 2026.
How many shares does Thomas E. Hogan own?
After the latest filing that states it, Thomas E. Hogan directly owned 765,249 shares of Cellebrite DI Ltd. (CLBT). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Thomas E. Hogan bought or sold stock recently?
The most recent open-market sale was on August 25, 2026: sold 25,299 shares of Cellebrite DI Ltd. (CLBT) for $286K at an average of $11.29.
How do I get alerts when Thomas E. Hogan files?
Follow Thomas E. Hogan on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Thomas E. Hogan filed 1 time in the last 90 days.

From SEC Forms 3, 4, 5 and 144 filed by Thomas E. Hogan (SEC CIK 0002013619). Totals count each trade once, skipping amendments whose original is on file, from Jul 7, 2026 on. View on SEC EDGAR